Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure
- 28 February 2007
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 13 (1) , 42-49
- https://doi.org/10.1016/j.cardfail.2006.09.004
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Measurement of Midregional Proadrenomedullin in Plasma with an Immunoluminometric AssayClinical Chemistry, 2005
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewBMJ, 2005
- Vasopressin antagonism: A future treatment option in heart failureEuropean Heart Journal, 2005
- Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?Clinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human PlasmaClinical Chemistry, 2004
- Predicting Mortality Among Patients Hospitalized for Heart FailureJAMA, 2003
- Clinical applications of B-type natriuretic peptide (BNP) testingEuropean Heart Journal, 2003
- Cardiac Hormones as Diagnostic Tools in Heart FailureEndocrine Reviews, 2003
- Adrenomedullin in Heart FailureHypertension Research, 2003
- Hormones and Hemodynamics in Heart FailureNew England Journal of Medicine, 1999